Shirley D. Jones

680 total citations · 1 hit paper
10 papers, 447 citations indexed

About

Shirley D. Jones is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Shirley D. Jones has authored 10 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Genetics. Recurrent topics in Shirley D. Jones's work include Diabetes Management and Research (8 papers), Diabetes and associated disorders (7 papers) and Pancreatic function and diabetes (7 papers). Shirley D. Jones is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes and associated disorders (7 papers) and Pancreatic function and diabetes (7 papers). Shirley D. Jones collaborates with scholars based in New Zealand, United States and China. Shirley D. Jones's co-authors include Benjamin J. Wheeler, Carla M. Frewen, Martin de Bock, Renee A. Meier, Anirban Roy, Natalie Kurtz, John Shin, Niranjala Hewapathirana, Robert A. Vigersky and Benyamin Grosman and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Metabolism.

In The Last Decade

Shirley D. Jones

9 papers receiving 440 citations

Hit Papers

Improved Glycemic Outcomes With Medtronic MiniMed Advance... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
    2021 192 citations Renee A. Meier, Chris Frampton et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirley D. Jones New Zealand 8 387 289 254 31 25 10 447
Ajuah Davis United States 8 164 0.4× 87 0.3× 65 0.3× 11 0.4× 11 0.4× 12 334
J. M’Bemba France 10 170 0.4× 80 0.3× 35 0.1× 11 0.4× 15 0.6× 20 276
Isabelle Isa Kristin Steineck Denmark 9 447 1.2× 253 0.9× 258 1.0× 7 0.2× 30 1.2× 12 483
Matteo Bonomo Italy 10 135 0.3× 166 0.6× 27 0.1× 6 0.2× 25 1.0× 17 479
Weronika Bielka Poland 6 129 0.3× 53 0.2× 45 0.2× 4 0.1× 17 0.7× 9 264
Agnieszka Przezak Poland 6 129 0.3× 53 0.2× 45 0.2× 4 0.1× 17 0.7× 9 264
Jennifer McVean United States 9 143 0.4× 99 0.3× 85 0.3× 4 0.1× 17 0.7× 16 302
Anita Jeyam United Kingdom 9 178 0.5× 106 0.4× 128 0.5× 2 0.1× 49 2.0× 19 299
Konstantinos Kitsios Greece 6 363 0.9× 263 0.9× 183 0.7× 23 0.9× 11 426
Amoolya Gowda Denmark 6 300 0.8× 115 0.4× 102 0.4× 17 0.5× 8 0.3× 13 322

Countries citing papers authored by Shirley D. Jones

Since Specialization
Citations

This map shows the geographic impact of Shirley D. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley D. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley D. Jones more than expected).

Fields of papers citing papers by Shirley D. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirley D. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley D. Jones. The network helps show where Shirley D. Jones may publish in the future.

Co-authorship network of co-authors of Shirley D. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Shirley D. Jones. A scholar is included among the top collaborators of Shirley D. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirley D. Jones. Shirley D. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
4.
Lewis, Dana, Hamish Crocket, Renee A. Meier, et al.. (2023). Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial. Diabetes Technology & Therapeutics. 25(4). 250–259. 12 indexed citations
5.
Frewen, Carla M., et al.. (2023). Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections. Diabetes Care. 46(3). 628–632. 22 indexed citations
6.
Lewis, Dana, Hamish Crocket, Renee A. Meier, et al.. (2022). Open-Source Automated Insulin Delivery in Type 1 Diabetes. New England Journal of Medicine. 387(10). 869–881. 93 indexed citations
7.
8.
Meier, Renee A., Chris Frampton, Carla M. Frewen, et al.. (2021). Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes. Diabetes Care. 44(4). 969–975. 192 indexed citations breakdown →
9.
Manning, Patrick, et al.. (2003). HRT does not improve urinary albumin excretion in postmenopausal diabetic women. Diabetes Research and Clinical Practice. 60(1). 33–39. 23 indexed citations
10.
Sutherland, W. H. F., et al.. (2001). Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism. 50(3). 319–324. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajuah Davis Breakdown of academic impact, for papers by J. M’Bemba Breakdown of academic impact, for papers by Isabelle Isa Kristin Steineck Breakdown of academic impact, for papers by Matteo Bonomo Breakdown of academic impact, for papers by Weronika Bielka Breakdown of academic impact, for papers by Agnieszka Przezak Breakdown of academic impact, for papers by Jennifer McVean Breakdown of academic impact, for papers by Anita Jeyam Breakdown of academic impact, for papers by Konstantinos Kitsios Breakdown of academic impact, for papers by Amoolya Gowda
Rankless by CCL
2026